Sydney-based Mercury Capital cleared to buy half of Nirvana Health
Joint-venture plan for primary care clinics.
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
An Australian private equity fund has been cleared to buy half of Nirvana Health, the country's largest independent primary health care group.
Mercury Medical Holdings, ultimately controlled by Sydney-based Mercury Capital Fund 2, has bought half of NMH Holdings, the holding company of Nirvana Health's business, for an undisclosed amount. The two plan to be joint venture partners for Nirvana's 37 primary care clinics, most of which are in Auckland, the Overseas Investment Office approval documents show.
Former health minister Tony Ryall is a member of NMH's board of directors, alongside Nirvana's Mahesh Patel, and Mercury directors Clark Perkins, Oliver Tompkins and Chris Criddle. Nirvana Health says it serves 200,000 enrolled patients across its clinics. It first began in 1977 when Kantilal and Ranjna Patel took over a one-doctor general practice in Otara.
The $A300 million Mercury Capital Fund 2, which was raised in 2015, is also invested in commercial printing company Blue Star in New Zealand, contract research organisation Novotech, label printer Hexagon, Sydney-based physiotherapy provider HealthStrong, and Australia's second-largest day hospital operator Nexus Day Hospitals.
The two parties "will work together to expand the medical business, through the opening of new sites, acquisitions of similar businesses and geographic expansion outside the Auckland market," the OIO documents say.
(BusinessDesk)
Sophie Boot
Thu, 31 Aug 2017
Thu, 31 Aug 2017
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Sydney-based Mercury Capital cleared to buy half of Nirvana Health
69763